Tanmoy Sanyal

I am a principal scientist at Amgen, working at the intersection of structural biology, antibody design, and applied machine learning. Previously I re-designed peptide based drugs for enhanced half-lives using computational methods, as a protein design scientist at Novo Nordisk. Before that, I was a postdoc in the Sali lab at University of California San Francisco, where I developed integrative protein structure determination methods from chemical cross-link data. I received my PhD in Chemical Engineering from University of California Santa Barbara, where I was advised by M. Scott Shell, and developed variational inference algorithms for molecular mechanics models of equilibrium phase behavior and protein biophysics.